Patents
Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848)
08/2005
08/24/2005CN1659136A Novel sodium channel blockers
08/18/2005WO2005075410A1 New compounds, methods for their preparation and use thereof
08/18/2005US20050182025 Amidinylphenyl compounds and their use as fungicides
08/18/2005DE10215908B4 Acyl-3-carboxyphenyl-harnstoffderivate und deren Verwendung als Arzneimittel Acyl-3-carboxy-phenyl-urea derivatives and their use as medicaments
08/18/2005CA2552942A1 New compounds, methods for their preparation and use thereof
08/17/2005EP1564206A1 Method for preparing 2-hydroxy-6-ureidocarbonyl naphthalene derivative
08/17/2005EP1562891A1 4-aminomethyl-1-aryl-cyclohexylamine derivatives
08/17/2005CN1656237A Antiviral inhibition of capsid proteins
08/16/2005US6930130 For use in therapy of schizophrenia, Parkinson's disease, and Alzheimer's disease
08/16/2005US6930106 Inhibitors of HCV NS5B polymerase
08/11/2005US20050176766 2,3-Oxidosqualene-lanosterol cyclase inhibitors
08/11/2005US20050176689 For therapy, useful as regulators of cell proliferation and differentiation, and particularly as agents for treating skin-related diseases
08/10/2005EP1561749A1 TNF-Alpha production inhibitors for the treatment of autoimmune diseases
08/10/2005EP1560809A1 Cyclohexylurea derivatives
08/10/2005EP1333792A4 Novel coupler for use in oxidative hair dyeing
08/10/2005EP1157002B1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
08/10/2005CN1653042A Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
08/10/2005CN1653037A Substituted tetracycline compounds
08/10/2005CN1653025A NK1 antagonists
08/04/2005WO2005070871A2 Amino alcohol derivatives and their activity as renin inhibitors
08/04/2005WO2005040355A3 Tao kinase modulators and methods of use
08/04/2005US20050171372 Novel o-isopropylisourea salts and process for the production thereof
08/04/2005US20050171366 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde; efficient synthesis of intermediates which are readily amenable to the large scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors
08/04/2005DE10246434B4 Carboxyalkoxy-substituierte Acyl-carboxyphenyl-harnstoffderivate und ihre Verwendung als Arzneimittel Carboxyalkoxy-substituted acyl-carboxyphenyl urea derivatives and their use as medicaments
08/04/2005CA2553840A1 Amino alcohol derivatives and their activity as renin inhibitors
08/03/2005EP1558591A2 Modulation of anxiety through blockade of anandamide hydrolysis
08/03/2005EP1558574A1 Novel n-hydroxy thiourea, urea and amide compounds and the pharmaceutical compositions comprising the same
08/03/2005EP1558567A1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds
08/03/2005CN1649905A Incorporable photoinitiator
08/03/2005CN1649859A Substituted phenylacetamides and their use as glucokinase activators
08/03/2005CN1649834A Novel propionic acid derivative
08/03/2005CN1649833A Amidinylphenyl compounds and their use as fungicides
08/03/2005CN1649582A Amino-methyl substituted tetracycline compounds
08/03/2005CN1213038C Benzophenones as inhibitors of reverse transcriptase
08/03/2005CN1213022C Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
08/02/2005US6924275 Aminophenol derivatives and their use in cosmetics
08/02/2005CA2170020C Retroviral protease inhibiting compounds
07/2005
07/28/2005WO2005068420A1 Urea and thiourea compounds and compositions for cholesterol management and related uses
07/28/2005WO2005068417A1 Novel triphenylmethane derivative, organic gellant containing the same, organic gel, and organic fiber
07/27/2005EP1556436A1 Polyamine derivatives, a process to make them, and their use
07/27/2005EP1556344A1 Treating syndrome x with substituted tetralins and indanes
07/27/2005EP1556340A1 Phenylethanolamine derivatives for the treatment of respiratory diseases
07/27/2005EP1556339A2 Carboxyalkoxy-substituted acyl-carboxyphenyl-urea derivatives, production method and use thereof as medicine
07/27/2005EP1047418B1 Inhibition of raf kinase using substituted heterocyclic ureas
07/27/2005CN1646486A Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
07/27/2005CN1646485A Acyl-4-carboxyphenylurea derivatives, method for production and use thereof
07/27/2005CN1646480A Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition
07/21/2005WO2004050609A8 Substituted ureas and carbamates
07/21/2005US20050159585 Forming acyl azide function on acid group of amino acid derivative, then transforming to isocyanate
07/21/2005US20050159584 O-succinimidyl-2-[(9H-fluoren-9-ylmethoxy)carbonylamino]-ethylcarbamate's used as monomers active in the synthesis of di- and tri-substituted ureas and urea oligomers
07/21/2005US20050159570 Molecularly imprinted polymer obtainable by polymerization of hexamethyl phosphonamide based monomer in presence of a template molecule and extraction; crosslinking; separation of enantiomers, resolution
07/21/2005US20050159416 Substituted urea derivatives activate the cardiac sarcomere by potentiating cardiac myosin; systolic heart failure including congestive heart failure; 1-[3-(1-Acetyl-piperidin-3-yloxy)-5-fluoro-phenyl]-3-(6-methoxy-pyridin-3-yl)-urea
07/21/2005US20050159412 hydroxamic acid and N-formyl hydroxylamine compounds which inhibit the activity of the bacterial enzyme known as peptide deformylase
07/20/2005EP1284959B1 Compounds for modulating the rage receptor
07/19/2005US6919339 ABCA-1 elevating compounds
07/14/2005WO2005063699A1 N-aryloxypropanolyl-n’-phenethyl-urea
07/14/2005WO2005063222A1 Hsp90 FAMILY PROTEIN INHIBITOR
07/14/2005WO2005063018A1 Haloalkene compounds, process for their production and pesticides containing them
07/14/2005US20050154230 Urea derivatives
07/13/2005EP1161415B1 N-cyanomethylamides as protease inhibitors
07/13/2005EP1144364B1 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
07/13/2005CN1636986A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636985A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636984A Benzophenones as inhibitors of reverse transcriptase
07/12/2005US6916837 Such as 2-(6-amidino-2-naphthyloxy)-5-methanesulfonyl-aminobenzoic acid trifluoroacetate; blood coaggulation factor VII inhibitors
07/12/2005CA2238859C Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
07/07/2005WO2005061445A1 Methods for carbon isotope labeling synthesis by rhodium-promoted carbonylation via isocyanate using azides and carbon-isotope monoxide
07/07/2005WO2005061443A2 Benzoyl-substituted phenylalanine amides
07/07/2005US20050148644 Ligands for Inosine-5'-monophosphate dehydrogenase; antiviral, antiinflammatory, antibiotics, transplant rejection, autoimmune disease, , antipsoriatic immunosuppressants; 3-uriedo benzyl carbamate derivatives; high potency, side effects reduction; bioavailability; antivascular hyperproliferative
07/07/2005CA2548442A1 Benzoyl-substituted phenylalanine amides
07/06/2005EP1216225B1 Novel derivatives of dicarboxylic acid having pharmaceutical properties
07/06/2005CN1634879A N-phenyl formamide-acrylamide and its synthesis method
07/05/2005US6913629 Building blocks containing isocyanate groups and their use for functionalizing or modifying compounds or surfaces
07/05/2005CA2160128C Urea and amide derivatives and their use in the control of cell membrane potassium channels
07/05/2005CA2151377C Aminomethylindans, -benzofurans and -benzothiophenes
06/2005
06/30/2005WO2005058798A2 Compounds having selective cytochrome p450rai-1 or selective cytochrome p450rai-2 inhibitory activity and methods of obtaining the same
06/30/2005WO2005020899A3 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity
06/30/2005US20050143456 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
06/30/2005US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion
06/30/2005US20050143352 Substituted tetracycline compounds
06/30/2005CA2550123A1 Compounds having selective cytochrome p450rai-1 or selective cytochrome p450rai-2 inhibitory activity and methods of obtaining the same
06/29/2005EP1548001A1 Fluorinated urethane compounds and compositions containing the same
06/29/2005CN1208329C Aniline derivatives
06/29/2005CN1208314C Factor VIIA inhibitor (thio) urea derivatives, their preparation and their use
06/23/2005WO2005056520A1 Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy
06/23/2005WO2005056519A1 Alpha-ketoamide derivative, and production method and use thereof
06/23/2005WO2005033230A3 Low-cure powder coatings, related coating method and coated substrates
06/23/2005WO2002068380A8 Synthetic excitatory amino acids
06/23/2005US20050137230 Factor Xa-inhibitors; preventing thromboembolic illnesses and tumors; 2-amino-N-(2'-methylsulfonylbiphenyl-4-yl)-3-phenylpropionamide
06/23/2005US20050137174 Broad spectrum antibiotics; N-t-Butylcarbonyloxymethyl (9-[(2,2, dimethyl-propyl amino)-methyl]-minocycline)carbamate; antiinflammatory, anticarcinogenic, viricde, bactericide; gram positive and gram negative bacterial infection; viral infection; prodrugs
06/23/2005CA2547863A1 Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy
06/22/2005EP1542687A1 Small organic molecules that increase the activity of gelatinase a in ocular cells
06/22/2005EP1542667A2 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
06/22/2005EP1177200B1 Ligands for metabotropic glutamate receptors
06/22/2005EP1175392B1 Contrast media
06/22/2005EP1100763B1 Diketoacid-derivatives as inhibitors of polymerases
06/22/2005EP0955797B1 Diformylurea and reaction products of urea and carboxylic acids
06/22/2005CN1207288C Retroviral protease inhibiting compounds
06/21/2005US6908957 Curable electron donor compounds
06/21/2005US6908935 Calcium receptor modulating agents
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 99